Blood level of middle molecular substances during uraemia and haemodialysis.
作者信息
Dzúrik R, Bozek P, Reznícek J, Oborníková A
出版信息
Proc Eur Dial Transplant Assoc. 1973;10(0):263-70.
PMID:4802412
Abstract
摘要
相似文献
1
Blood level of middle molecular substances during uraemia and haemodialysis.尿毒症及血液透析期间中分子物质的血药浓度
Proc Eur Dial Transplant Assoc. 1973;10(0):263-70.
2
beta 2-Microglobulin and other low molecular weight proteins in haemodiafiltrates and in haemofiltrates.血液透析滤过液和血液滤过液中的β2微球蛋白及其他低分子量蛋白质。
Int J Tissue React. 1984;6(1):71-4.
3
Are standards and checklists needed in uremia therapy?尿毒症治疗中需要标准和检查表吗？
Kidney Int Suppl. 1985 Dec;17:S124-6.
4
[Hemodynamic changes during ultrafiltration and hemodialysis in uremia].[尿毒症患者超滤和血液透析过程中的血流动力学变化]
Z Urol Nephrol. 1979 Jan;72(1):3-8.
5
[Hemofiltration in uremia: clinical approach].
J Urol Nephrol (Paris). 1977 Sep;83(9):712-7.
6
Serum middle molecules in uremia.尿毒症患者的血清中分子物质
Artif Organs. 1981;4 Suppl:143-50.
7
Dialyzers and dialysis membranes. Research directions.透析器与透析膜。研究方向。
ASAIO J. 1996 May-Jun;42(3):133-5.
8
Determination of middle molecules in uremic patients.尿毒症患者中分子物质的测定。
Chin Med J (Engl). 1985 Feb;98(2):115-20.
9
Long-term haemodialysis treatment with sodium removal by convection.通过对流进行钠清除的长期血液透析治疗。
Proc Eur Dial Transplant Assoc. 1981;18:146-52.
10
Transport of small, middle, and large molecular weight substances in a dual filtration artificial kidney.双滤过人工肾中小分子、中分子和大分子物质的转运
Artif Organs. 1981;4 Suppl:104-9.
引用本文的文献
1
Peritoneal dialysability of "uraemic substances".“尿毒症物质”的腹膜透析性
Int Urol Nephrol. 1981;13(2):193-8. doi: 10.1007/BF02082064.
2
Middle molecular substances in acute renal failure.急性肾衰竭中的中分子物质。
Int Urol Nephrol. 1982;14(1):67-73. doi: 10.1007/BF02082386.
3
Serum and ultradiafiltrate middle molecules in hemodialysed patients.血液透析患者的血清和超滤液中的中分子物质
Int Urol Nephrol. 1979;11(3):223-8. doi: 10.1007/BF02081963.
Zotero 插件